GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Total Stockholders Equity

Microba Life Sciences (ASX:MAP) Total Stockholders Equity : A$49.25 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences Total Stockholders Equity?

Microba Life Sciences's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$49.25 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Microba Life Sciences's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.11. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Microba Life Sciences's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.03.

Microba Life Sciences Total Stockholders Equity Historical Data

The historical data trend for Microba Life Sciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences Total Stockholders Equity Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23
Total Stockholders Equity
33.54 38.57

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Total Stockholders Equity 38.06 33.54 45.36 38.57 49.25

Microba Life Sciences  (ASX:MAP) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Microba Life Sciences's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(49.248-0)/447.852
=0.11

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Microba Life Sciences's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.868 + 0.511) / 49.248
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microba Life Sciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Microba Life Sciences (ASX:MAP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Total Stockholders Equity
Comparable Companies
ASX:GSS ASX:IIQ ASX:RHY ASX:LDX ASX:CTE ASX:GTG ASX:BDX ASX:IBX TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH ILMN DGX
Traded in Other Exchanges
N/A
Address
324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Website
https://www.microba.com
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines